Viking Therapeutics
VKTX
#3666
Rank
A$4.19 B
Marketcap
$37.41
Share price
-6.61%
Change (1 day)
-66.55%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2024 (TTM): -A$0.17 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.19 Billion28.02%
2023 -A$0.15 Billion24.73%
2022 -A$0.12 Billion25.24%
2021 -A$90.96 Million39.23%
2020 -A$65.33 Million53.21%
2019 -A$42.64 Million16.84%
2018 -A$36.5 Million7.22%
2017 -A$34.04 Million39.68%
2016 -A$24.37 Million-37.05%
2015 -A$38.72 Million6.94%
2014 -A$36.2 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.84 Billion 358.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.22 M-103.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$10.43 Million-94.27%๐Ÿ‡บ๐Ÿ‡ธ USA